CWI1-2 (hydrochloride)
CWI1-2 hydrochloride is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and shows promising anti-leukemic effects[1].
Product Specifications
CAS Number
[2408590-37-2]
UNSPSC
12352005
Hazard Statement
H314
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cwi1-2-hydrochloride.html
Purity
98.27
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
OC(C=C1)=C(C=C1Cl)/C=N/N=C(N/N=C\C(C=C2Cl)=C(C=C2)O)\N/N=C/C(C=C3Cl)=C(C=C3)O.[H]Cl
Molecular Formula
C22H18Cl4N6O3
Molecular Weight
556.23
Precautions
H314
References & Citations
[1]Hengyou Weng, et al. The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022 Dec 12;40 (12) :1566-1582.e10.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2261-41A-HRP 100 µL
CD10 (CALLA, Common Acute Lymphocytic Leukemia Antigen, Neprilysin, NEP, Neutral Endopeptidase 24.11, EC3.4.24.11) (HRP) discontinued
Ask
View Details 
585130-01 20 µg
Kynurenine 3-monooxygenase, Recombinant, Rat, aa1-384, His-SUMO-Tag
Ask
View Details